Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
By putting the weights of a highly capable, 33B-parameter agentic model in the hands of researchers and startups, Poolside is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results